Skip to main content

Table 1 General characteristics of nursing mothers at the baseline of study

From: The effect of vitamin D supplementation on body composition in nursing mothers with overweight or obesity: a randomized double-blind placebo-controlled clinical trial

Variable

PLa

(n = 29)

VD1a

(n = 32)

VD2a

(n = 29)

P-value

Age(year)

31 ± 4.3

31.2 ± 5.5

31 ± 4.8

0.9b

Baseline BMI (kg/m2)

30.1 ± 3.1

30.5 ± 3.6

30.8 ± 3.2

0.7b

Pregnancy weight gain (kg)

15 ± 5.6

12.5 ± 4.4

13.9 ± 5.6

0.1b

Weight before pregnancy (kg)

68.9 ± 9.7

71.5 ± 12.3

70 ± 8.8

0.6b

Sun exposure of mothers (minutes/day)*

Baseline

10 (0–17.5)

10 (0–27)

10 (0–15)

0.7c

Week 12

0 (0–5)

0 (0–0)

0 (0–0)

0.4c

Birth interval (year)*

4.8 (0–7.5)

3 (0–8.2)

4 (0–7.5)

0.7c

Number of children (n)*

2 (1–2)

2 (1–2)

2 (1–2)

0.9c

Hemoglobin (gr/dl)*

11.8 (11.3–12.4)

11.6 (11.2–12.6)

12.1 (11–12.5)

0.8c

Anemia n (%)

16 (55.2)

19 (59.4)

13 (44.8)

0.5d

Abortion history n (%)

6 (20.6)

9 (28.1)

7 (24.1)

0.7d

Cesarean delivery n (%)

24 (82.7)

31) 96.8)

28 (96.5)

0.06d

Multiple pregnancy n (%)

0 (0)

1 (13.1)

0 (0)

0.4d

Use of multivitamin during pregnancy n (%)

29 (100)

32 (100)

29 (100)

–

Use of iron supplement after delivery n (%)

29 (100)

32 (100)

29 (100)

–

Duration of breast feeding (weeks)

12

12

12

–

Exclusive breast feeding n (%)

29 (100)

32 (100)

29 (100)

–

Usage of sunscreen n (%)

Baseline

Always

Sometimes

Never/Rarely

12 (41.4)

6 (20.7)

11 (37.9)

14 (43.8)

3 (9.4)

15 (46.9)

10 (34.5)

1 (3.4)

18 (62.1)

0.1d

Week 12

Always

Sometimes

Never/Rarely

14 (48.3)

3 (10.3)

12 (41.4)

12 (37.5)

6 (18.8)

14 (43.8)

10 (34.5)

2 (6.9)

17 (58.6)

0.4d

Physical activity level n (%)e

Baseline

Low

Moderate

High

10 (34.4)

11 (37.9)

8 (27.5)

17 (53.1)10 (31.2)

5 (15.6)

15 (51.7)

8 (27.5)

6 (20.6)

0.5d

Week 12

Low

Moderate

High

6 (20.6)

7 (24.1)

16 (55.1)

10 (31.2)

6 (18.7)

16 (50)

7 (24.1)

3 (10.3)

9 (65.5)

0.5d

  1. The results are described as mean ± standard deviation or number %
  2. *The results are described as median ± interquartile range (Q1 and Q3)
  3. aThree groups of 2000 IU vitamin D3/d (VD1), 4000 IU vitamin D3/d (VD2), and placebo (PL)
  4. bOne Way ANOVA Test
  5. ck Independent Samples (Kruskal-Wallis H Test)
  6. dChi Square Test
  7. eLow: score less than 600 MET minutes per week, moderate: score 600–3000 MET minutes and high: score more than 3000 MET minutes